Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial | Scientific Reports
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion | PLOS ONE
In Vivo Pharmacology and Toxicology Evaluation of Polyethylene Glycol-Conjugated Interferon β-1a | Journal of Pharmacology and Experimental Therapeutics
Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
A BRANCHED METHOXY 40 KDA POLYETHYLENE GLYCOL (PEG) MOIETY OPTIMIZES THE PHARMACOKINETICS (PK) OF PEGINTERFERON a-2A (PEG-IFN) AND MAY EXPLAIN ITS ENHANCED EFFICACY IN CHRONIC HEPATITIS C (CHC)
Adjustment during Peg-IFN treatment for HBeAg-negative CHB patients.... | Download Scientific Diagram
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study | PLOS ONE
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study | BMC Pharmacology | Full Text
EP1087778B1 - Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c - Google Patents
Peginterferon alfa-2a Pegasys - Treatment - Hepatitis C Online
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. - Abstract - Europe PMC
Frontiers | Interferon and Hepatitis B: Current and Future Perspectives
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
Chronic treatment with peg-IFN-α reduces peripheral disease parameters... | Download Scientific Diagram
Peg-INF Inj 180mcg 1Vial
JCM | Free Full-Text | Short-Term Peg-IFN α-2b Re-Treatment Induced a High Functional Cure Rate in Patients with HBsAg Recurrence after Stopping Peg-IFN α-Based Regimens
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus | Antimicrobial Agents and Chemotherapy
Characterization and biologic activity of PPB-PEG-IFN-γ. A) Schematic... | Download Scientific Diagram
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG- IFN-β-1a | Bioanalysis
Peginterferon Alfa-2a (40 kD) Stopping Rules in Chronic Hepatitis B: A Systematic Review and Meta-Analysis of Individual Participant Data - Vedran Pavlovic, Lei Yang, Henry Lik-Yuen Chan, Jinlin Hou, Harry L Janssen,
![PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/773a2ed1c92ed98831267442933ac3793394f2a7/4-Figure1-1.png "PDF] Consensus Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B | Semantic Scholar")